115 related articles for article (PubMed ID: 26938684)
21. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
22. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
[TBL] [Abstract][Full Text] [Related]
23. Identification of pyridinoline, a collagen crosslink, as a novel intrinsic ligand for the receptor for advanced glycation end-products (RAGE).
Murakami Y; Fujino T; Kurachi R; Hasegawa T; Usui T; Hayase F; Watanabe H
Biosci Biotechnol Biochem; 2018 Sep; 82(9):1508-1514. PubMed ID: 29804507
[TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products augment experimental hepatic fibrosis.
Goodwin M; Herath C; Jia Z; Leung C; Coughlan MT; Forbes J; Angus P
J Gastroenterol Hepatol; 2013 Feb; 28(2):369-76. PubMed ID: 23173780
[TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.
Deluyker D; Evens L; Bito V
Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551
[TBL] [Abstract][Full Text] [Related]
26. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
27. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.
Candido R; Forbes JM; Thomas MC; Thallas V; Dean RG; Burns WC; Tikellis C; Ritchie RH; Twigg SM; Cooper ME; Burrell LM
Circ Res; 2003 Apr; 92(7):785-92. PubMed ID: 12623881
[TBL] [Abstract][Full Text] [Related]
28. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
29. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
[TBL] [Abstract][Full Text] [Related]
30. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
[TBL] [Abstract][Full Text] [Related]
31. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats.
Hou J; Zheng D; Fung G; Deng H; Chen L; Liang J; Jiang Y; Hu Y
Can J Physiol Pharmacol; 2016 Mar; 94(3):332-40. PubMed ID: 26751764
[TBL] [Abstract][Full Text] [Related]
32. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
Huang Y; Lin S; Zhou J
Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
[TBL] [Abstract][Full Text] [Related]
33. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
[TBL] [Abstract][Full Text] [Related]
34. Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats.
Wu F; Feng JZ; Qiu YH; Yu FB; Zhang JZ; Zhou W; Yu F; Wang GK; An LN; Ni FH; Wu H; Zhao XX; Qin YW; Luo HD
Atherosclerosis; 2013 Aug; 229(2):287-94. PubMed ID: 23880178
[TBL] [Abstract][Full Text] [Related]
35. Advanced glycation end product (AGE)-induced hepatic stellate cell activation via autophagy contributes to hepatitis C-related fibrosis.
He Y; Zhu J; Huang Y; Gao H; Zhao Y
Acta Diabetol; 2015 Oct; 52(5):959-69. PubMed ID: 26002589
[TBL] [Abstract][Full Text] [Related]
36. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
37. New insights into the mechanisms of diastolic dysfunction in patients with type 2 diabetes.
Bayraktar A; Canpolat U; Demiri E; Kunak AU; Ozer N; Aksoyek S; Ovunc K; Ozkan A; Yildiz OB; Atalar E
Scand Cardiovasc J; 2015 Jun; 49(3):142-8. PubMed ID: 25920390
[TBL] [Abstract][Full Text] [Related]
38. Plasma advanced glycation end products (AGEs), receptors for AGEs and their correlation with inflammatory markers in middle school-age children.
Accacha S; Rosenfeld W; Jacobson A; Michel L; Schnurr FJ; Shelov S; Ten S; Boucher-Berry C; Carey DE; Speiser PW; Lowell B; Conroy R; Klein M; Fennoy I; Rapaport R; Rosenbaum M
Horm Res Paediatr; 2013; 80(5):318-27. PubMed ID: 24217195
[TBL] [Abstract][Full Text] [Related]
39. RAGE upregulation and nuclear factor-kappaB activation associated with ageing rat cardiomyocyte dysfunction.
Gao ZQ; Yang C; Wang YY; Wang P; Chen HL; Zhang XD; Liu R; Li WL; Qin XJ; Liang X; Hai CX
Gen Physiol Biophys; 2008 Sep; 27(3):152-8. PubMed ID: 18981529
[TBL] [Abstract][Full Text] [Related]
40. Advanced glycation end products accelerate arteriosclerosis after renal transplantation through the AGE/RAGE/ILK pathway.
Liu X; Liu K; Wang Z; Liu C; Han Z; Tao J; Lu P; Wang J; Wu B; Huang Z; Yin C; Gu M; Tan R
Exp Mol Pathol; 2015 Oct; 99(2):312-9. PubMed ID: 26210487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
